Purpose Narcolepsy is a rare debilitating disorder for which multiple novel pharmacological
options have been approved as treatment for the past few years. The current study …

Background Obstructive sleep apnoea (OSA) is a common chronic respiratory disease
associated with a high burden of disabilities related to sleepiness and reduced quality of life …

Obstructive sleep apnea (OSA) is a disease that results from loss of upper airway muscle
tone leading to upper airway collapse during sleep in anatomically susceptible persons …

Excessive sleepiness (ES) is a symptom of obstructive sleep apnea (OSA) and narcolepsy
that has severe consequences. Wake-promoting drugs and stimulants are utilized as …

Obstructive sleep apnea (OSA) is a highly frequent sleep disorder in the middle-aged and
older population, and it has been associated with an increased risk of developing cognitive …

Excessive daytime sleepiness is considered as the prominent symptom in narcolepsy and
Obstructive Sleep Apnea (OSA). Pitolisant is a novel selective histamine H3 receptor …

Obstructive sleep apnea (OSA) is a highly prevalent condition characterized by episodes of
partial or complete breath cessation during sleep that induces sleep fragmentation (SF). One …

Excessive daytime sleepiness (EDS) and attentional deficits are often observed in people
with epilepsy. They may be the consequence of seizures and subclinical discharges as well …

Biological, environmental, behavioral, and social factors can influence sleep and lead to
sleep disorders or diseases. Sleep disorders are common, numerous, and heterogeneous in …

Sleep medicine is a truly multidisciplinary field that covers psychiatric, neurological and
respiratory conditions. As the field has developed it has become increasingly clear that there …